We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

289 hedge funds and large institutions have $1.81B invested in Supernus Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 119 increasing their positions, 78 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 25

53% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 78

8% more capital invested

Capital invested by funds: $1.67B → $1.81B (+$141M)

5% more funds holding

Funds holding: 274 → 289 (+15)

2.13% more ownership

Funds ownership: 99.31% → 101.44% (+2.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

45% less call options, than puts

Call options by funds: $8.25M | Put options by funds: $15.1M

Holders
289
Holders Change
+15
Holders Change %
+5.47%
% of All Funds
6.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
42
Increased
119
Reduced
78
Closed
25
Calls
$8.25M
Puts
$15.1M
Net Calls
-$6.8M
Net Calls Change
-$3.15M

Top Buyers

Rank Fund Capital Flow
1
NPIC
Neumeier Poma Investment Counsel
California
+$16.9M
2
Two Sigma Investments
Two Sigma Investments
New York
+$13M
3
UBS Group
UBS Group
Switzerland
+$12.1M
4
Macquarie Group
Macquarie Group
Australia
+$9.19M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$8.64M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$50.1M
2
Wells Fargo
Wells Fargo
California
-$8.95M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$6.18M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$5.96M
5
Morgan Stanley
Morgan Stanley
New York
-$5.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
SDIC
101
South Dakota Investment Council
South Dakota
$2.31M – – –
State of Wisconsin Investment Board
102
State of Wisconsin Investment Board
Wisconsin
$2.29M +$554K +14,900 +30%
SI
103
Shaker Investments
Ohio
$2.2M -$4.91K -132 -0.2%
Squarepoint
104
Squarepoint
New York
$2.18M +$1.63M +43,843 +240%
Comerica Bank
105
Comerica Bank
Texas
$2.01M +$53.4K +1,436 +3%
BA
106
Boston Advisors
Massachusetts
$1.92M +$167K +4,496 +9%
AAP
107
Aristotle Atlantic Partners
Florida
$1.79M +$1M +26,989 +112%
Citigroup
108
Citigroup
New York
$1.73M +$694K +18,659 +61%
JG
109
Jefferies Group
New York
$1.67M +$1.77M +47,641 New
CS
110
Credit Suisse
Switzerland
$1.6M -$647K -17,394 -28%
Nomura Holdings
111
Nomura Holdings
Japan
$1.58M +$636K +17,097 +63%
BWFA
112
Baltimore-Washington Financial Advisors
Maryland
$1.56M +$256K +6,874 +18%
RJA
113
Raymond James & Associates
Florida
$1.52M -$95.3K -2,562 -6%
AA
114
AQR Arbitrage
Connecticut
$1.52M +$1.62M +43,444 New
Tudor Investment Corp
115
Tudor Investment Corp
Connecticut
$1.45M +$214K +5,764 +16%
CIA
116
Capital Impact Advisors
Massachusetts
$1.45M – – –
US Bancorp
117
US Bancorp
Minnesota
$1.41M +$159K +4,268 +12%
HSA
118
Hussman Strategic Advisors
Maryland
$1.4M -$930K -25,000 -38%
Bank of Montreal
119
Bank of Montreal
Ontario, Canada
$1.4M -$71.1K -1,912 -5%
Thrivent Financial for Lutherans
120
Thrivent Financial for Lutherans
Minnesota
$1.4M +$106K +2,854 +8%
State of Tennessee, Department of Treasury
121
State of Tennessee, Department of Treasury
Tennessee
$1.4M +$54.1K +1,453 +4%
EGM
122
Engineers Gate Manager
New York
$1.39M -$203K -5,466 -12%
SEC
123
Seven Eight Capital
New York
$1.39M +$1.48M +39,655 New
DekaBank Deutsche Girozentrale
124
DekaBank Deutsche Girozentrale
Germany
$1.38M +$216K +5,800 +22%
IP
125
Isthmus Partners
Wisconsin
$1.36M -$203K -5,468 -20%
3 4
5
6 7

SUPN Hedge Fund Activity: Q1 2019 in Review

289 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q1 2019, worth a combined $1.81B — up 8.4% from $1.67B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new SUPN positions and 25 closed out — a net gain of 17 holders — while 119 added to existing stakes and 78 trimmed.

The largest buyer was Neumeier Poma Investment Counsel, adding an estimated $16.9M. The largest seller was Fidelity Investments, cutting an estimated $50.1M.

  • 289 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q1 2019, up from 274 in Q4 2018.
  • Funds reported $1.81B of Supernus Pharmaceuticals stock for Q1 2019, up 8.4% quarter-over-quarter.
  • 42 funds opened new Supernus Pharmaceuticals positions in Q1 2019 and 25 closed out, a net change of +17 holders.
  • The largest Supernus Pharmaceuticals buyer in Q1 2019 was Neumeier Poma Investment Counsel, an estimated $16.9M added.
  • The largest Supernus Pharmaceuticals seller in Q1 2019 was Fidelity Investments, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2019.